Profile
| Metric | Value |
|---|---|
| Full Name | Phreesia, Inc. |
| Ticker | NYSE: PHR |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | phreesia.com |
| Employees | 2,082 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.12 | |
| Price, 1D Change | +5.03% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.04 | |
| Revenue | $420M | |
| Revenue, 1Y Change | +17.83% | |
| EPS | -$1.02 | |
| EPS, 1Y Change | +59.49% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.02 | |
| EPS Estimate | $1.17 | |
| EPS Est. Change | +214.79% | |
| Revenue | $419.81M | |
| Revenue Estimate | $480.36M | |
| Revenue Est. Change | +14.42% | |
| Current Price | $17.12 | |
| Price Target | - | $29.00 |
| Price Tgt. Change | - | +69.39% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.23 | -$2.51 | -103.97% | |
| $0.08 | -$1.02 | -1,381.59% | |
| $1.17 | N/A | +214.79% | |
| $1.56 | N/A | +253.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $348.93M | $356.30M | +2.11% | |
| $419.05M | $419.81M | +0.18% | |
| $480.36M | N/A | +14.42% | |
| $552.38M | N/A | +31.58% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -35.52% | |
| Price, 3Y | -45.23% | |
| Market Cap, 1Y | -33.12% | |
| Market Cap, 3Y | -37.41% | |
| Revenue, 1Y | +17.83% | |
| Revenue, 3Y | +96.88% | |
| EPS, 1Y | +59.49% | |
| EPS, 3Y | +57.09% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.12 | |
| SMA 200 | $24.43 | |
| SMA 200 vs Price | +42.67% | |
| SMA 50 | $19.73 | |
| SMA 50 vs Price | +15.26% | |
| Beta | 1.04 | |
| ATR | $0.75 | |
| 14-Day RSI | 42.85 | |
| 10-Day Volatility | 34.80% | |
| 1-Year Volatility | 49.04% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $419.81M | |
| EPS | -$1.02 | |
| Gross Profit | $284.88M | |
| Gross Margin | 67.86% | |
| Operating Profit | -$58.10M | |
| Operating Margin | -13.84% | |
| Net Income | -$58.53M | |
| Net Margin | -13.94% | |
| EBITDA | -$30.21M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 1.78 | |
| Quick Ratio | 1.78 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 2.98 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 2.23 | |
| PB Ratio | 3.22 | |
| EV/EBITDA | 45.93 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $264.81M | |
| Cash & Equivalents | $84.22M | |
| Total Assets | $388.53M | |
| Current Assets | $203.29M | |
| Total Liabilities | $123.72M | |
| Current Liabilities | $114.02M | |
| Total Debt | $17.80M | |
| Short Term Debt | $9.01M | |
| Accounts Payable | $5.62M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $477.91M | |
| Operating Expenses | $342.98M | |
| Cost Of Goods Sold | $134.93M | |
| SG&A | $197.73M | |
| D&A | $27.89M | |
| Interest Expense | $0.00 | |
| Income Tax | $2.72M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $32.38M | |
| CFI | -$24.09M | |
| CFF | -$11.49M | |
| Capex | $24.09M | |
| Free Cash Flow | $8.29M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Mizuho | → | |
| Baird | → | |
| Needham | → | |
| JP Morgan | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| Barclays | ||
| Needham | → | |
| DA Davidson | → |
Analyst sentiment
Institutional ownership
Screeners with PHR
Data Sources & References
- PHR Official Website www.phreesia.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1412408/000141240825000114/0001412408-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1412408/000141240825000010/0001412408-25-000010-index.htm
- PHR Profile on Yahoo Finance finance.yahoo.com/quote/PHR
- PHR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/phr
FAQ
What is the ticker symbol for Phreesia, Inc.?
The ticker symbol for Phreesia, Inc. is NYSE:PHR
Does Phreesia, Inc. pay dividends?
No, Phreesia, Inc. does not pay dividends
What sector is Phreesia, Inc. in?
Phreesia, Inc. is in the Healthcare sector
What industry is Phreesia, Inc. in?
Phreesia, Inc. is in the Health Information Services industry
What country is Phreesia, Inc. based in?
Phreesia, Inc. is headquartered in United States
When did Phreesia, Inc. go public?
Phreesia, Inc. initial public offering (IPO) was on July 18, 2019
Is Phreesia, Inc. in the S&P 500?
No, Phreesia, Inc. is not included in the S&P 500 index
Is Phreesia, Inc. in the NASDAQ 100?
No, Phreesia, Inc. is not included in the NASDAQ 100 index
Is Phreesia, Inc. in the Dow Jones?
No, Phreesia, Inc. is not included in the Dow Jones index
When was Phreesia, Inc. last earnings report?
Phreesia, Inc.'s most recent earnings report was on December 8, 2025
When does Phreesia, Inc. report earnings?
The next expected earnings date for Phreesia, Inc. is March 12, 2026